US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist
  • 6.300
  • -0.490-7.22%
Close Jan 7 16:00 ET
  • 6.300
  • 0.0000.00%
Post 16:01 ET
196.16MMarket Cap-2.37P/E (TTM)

Acrivon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Acrivon Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 0.000 --
-- 2024/Q4 -- / 0.000 --
-- 2024/Q3 0.000 / 0.000 --
-- 2024/Q2 0.000 / 0.000 --
-- 2024/Q1 0.000 / 0.000 --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Acrivon Therapeutics Earnings Reports

  • Acrivon Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 20:08

  • Acrivon Therapeutics | 8-K: Acrivon Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

    Nov 13, 2024 20:03

  • Acrivon Therapeutics | 8-K: Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

    Aug 13, 2024 20:02

  • Acrivon Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13, 2024 19:42

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data